generic drugs

Generic Drug Production to be Impacted by UK-India FTA? 

India’s First Compulsory Licence: Patents vs Public Health?

In a move with far reaching implications for the debates around pharmaceutical patents, innovation and access to medicines, the Indian patent office issued its first ever compulsory licence in the post TRIPS era. While health activists, generic manufacturers and several academics lauded the decision, the multinational pharmaceutical industry was up in arms.